A detailed history of Black Rock Inc. transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,266 shares of SNOA stock, worth $6,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,266
Previous 2,266 -0.0%
Holding current value
$6,480
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.14 - $0.77 $85 - $468
-609 Reduced 21.18%
2,266 $0
Q2 2021

Aug 11, 2021

BUY
$7.12 - $9.15 $20,470 - $26,306
2,875 New
2,875 $21,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.87M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.